Researchers used PET scans to analyze 38 patients with non-Hodgkin's lymphoma treated with 90 ibritumomab tiuxetan. The study found that 89% of patients were in complete or partial remission after treatment, with a higher response rate for patients with limited cancer progression.
Researchers at SNM's 55th Annual Meeting present a study on pre-targeting strategies that combine molecular imaging techniques with targeted therapy, offering personalized medicine to cancer patients. This approach can increase the effectiveness of therapies and minimize discomfort during treatment.
Researchers say combined PET/CT scanning can enable doctors to determine if ovarian cancer has spread without surgery, reducing unnecessary surgeries and complications. The technology showed promising results in accurately staging early-stage ovarian cancer patients.
A recent survey of pediatric hospitals reveals a lack of universally applied standards for administering radiopharmaceutical doses to children. Experts recommend establishing guidelines that balance high-quality image resolution with low radiation exposure, taking into account each child's unique profile.
Researchers found altered dopamine activity in individuals with social anxiety disorder, suggesting a biological cause for the dysfunction. The study provides evidence of a physical component to social anxiety and may lead to new therapeutic approaches.
Researchers used PET and SPECT imaging to monitor the effectiveness of a new therapy, which successfully preserved healthy heart tissue and corrected blood flow imbalance. Nearly 50% of repaired artery segments showed normalization of glucose metabolism and coronary blood flow.
Recent data from the National Oncologic PET Registry (NOPR) shows that PET scans can dramatically change treatment plans for cancer patients, with a 36.5% change in treatment or no-treatment decisions reported.
Researchers used PET imaging with fluorodeoxyglucose (FDG) to classify different types of dementia, achieving over 94% accuracy. The study suggests that early diagnosis using FDG-PET may improve prognosis for patients with mild cognitive impairment and other forms of dementia.
A multi-institutional study found PET more reliable than CT in characterizing lung nodules as malignant. PET's superior specificity led to correctly classifying 58% of benign nodules misclassified on CT.
Researchers discovered that astatine-211 can kill residual cancer cells without harming sensitive brain tissue, leading to longer survival rates among patients. The isotope's potency and short lifespan make it a promising treatment option for brain tumors.
A recent study published in the Journal of Nuclear Medicine found that PET/CT imaging significantly outperforms conventional imaging for detecting malignant tumors in children. The imaging modality provides additional information about cancer in children, potentially sparing them from overtreatment.
A study highlights the need for improved patient information and counseling on nuclear medicine procedures, which can trigger radiation alarms in public places. Healthcare professionals, especially those in outpatient facilities, require formal training and standardization of instructions to ensure patient safety.
Researchers used PET imaging and bioluminescence to track stem cell behavior in small animal models, determining their fate and potential applications in treating heart diseases, brain disorders, and cancer. The unique combination of these imaging techniques offers a reliable method for labeling stem cells.
Researchers found that quantitative index adds accurate information about patients' responses to first-line chemotherapy, improving tumor response prediction. This method can also identify disease transformation and shorten treatment for favorable responders.
A ventilation/perfusion lung scan (V/Q scan) is a reliable alternative to CT angiograms in diagnosing pulmonary embolisms, especially in young women. The study found that V/Q scans can exclude pulmonary embolism with low probability clinical assessment, reducing radiation exposure and breast cancer risk.
The Society of Nuclear Medicine and Molecular Imaging has revised its nuclear medicine technologist's scope of practice, reflecting changes in technology and molecular imaging. The updated document includes procedures such as CT scans and administering contrast.
Researchers found that antidepressant medicines normalized decreased brain blood flow in patients with depression, while electroconvulsive therapy was associated with additional decreases. Objective imaging evaluations may support subjective clinical decisions in treating depression.
SNM presented special recognition awards to 7 lawmakers who support the profession. The organization highlighted their dedication to patient care and safety through initiatives like the CARE Act. SNM's annual meeting will be held June 2-6 at the Washington Convention Center.
The Society of Nuclear Medicine and Molecular Imaging has developed a broad definition for molecular imaging, capturing the essence of an evolving and multidisciplinary field. The definition provides a concise explanation of the meaning of molecular imaging, including techniques such as radiotracer imaging, MRI, and optical imaging.
Scientists have discovered a statistical relationship between brain levels of the enzyme monoamine oxidase A (MAO) A and aggressive personality in healthy non-violent volunteers. The study found that higher MAO A activity was associated with less aggressive behavior, while lower MAO A activity was linked to more aggressive tendencies.
A new study demonstrates the value of PET/CT in diagnosing and monitoring Crohn's disease, offering a non-invasive alternative to invasive endoscopy. The scan can accurately identify active disease and detect severe lesions, reducing the need for costly and side-effect-ridden treatments.
Researchers studied hypothyroidism's impact on brain metabolism and found a correlation between the condition and decreased metabolic activity in specific brain regions. These changes remain detectable even after thyroid hormone replacement therapy, suggesting a complex relationship between physical health and mental well-being.
Researchers at Rambam Health Care Campus in Israel have found that PET/CT imaging can accurately diagnose and localize vascular graft-related infections. The study shows promise as a single-step, noninvasive technique for complex patients, potentially sparing unnecessary high-risk operations.
Researchers unveiled the world's first simultaneous PET/MR images of the human brain, offering unprecedented imaging capabilities for neurological studies. The technology has the potential to revolutionize the assessment of Alzheimer's, Parkinson's, epilepsy, depression, and schizophrenia.
A study published at SNM's 54th Annual Meeting found that PET/CT imaging detected more sites of disease and identified women whose disease was likely to progress. The technique influenced treatment decisions in 59% of women with recurrent ovarian cancer, improving management outcomes.
Researchers from University of Pennsylvania and Philips team demonstrate improved image quality and shorter patient scan times with advanced molecular imaging technology. The study, released at SNM's 54th Annual Meeting, shows that TOF/PET imaging can achieve better quality images in less time, benefiting patients and doctors.
Beta-amyloid accumulation is linked to brain dysfunction even in normal elderly individuals, according to a study. Researchers used PIB PET scans to detect early pathological changes of Alzheimer's disease and demonstrated its potential for identifying those in need of treatment.
Researchers found that percutaneous ethanol injection (PEI) significantly reduces tumor volume and alleviates symptoms in patients with radioiodine-ineffective bone metastasis from thyroid cancer. PEI's effectiveness was also linked to improved quality of life for selected patients.
Researchers developed a novel imaging technique combining CT and PET scans to detect 'high-risk' plaque that causes heart attacks and strokes. The approach provides detailed information about the size of plaque, inflammation, and potential risks, offering new insights into atherosclerosis.
Researchers developed a 3D fusion technique combining CT angiography and nuclear imaging scans to improve the accuracy of diagnosing coronary artery disease. This technology significantly enhances diagnosis and could be used in the future with molecular imaging agents to detect and guide treatment.
Michael R. Zalutsky received the award for his significant contributions to medical science, especially in using molecular targeting to combat cancer. His research has had a substantial impact on therapeutic nuclear medicine and its applications.
Early metabolic imaging with PET accurately identifies patients responding to chemotherapy for esophageal cancer, noting a remarkably favorable outcome for metabolic responders. This study supports the use of PET-response-guided treatment to tailor multimodality therapy based on tumor biology.
Researchers developed a new imaging technique that combines functional and anatomical imaging to diagnose coronary artery disease more accurately. This 'synergy' approach uses software to integrate data from SPECT and CT angiography scans, providing clearer pictures of the heart muscle and coronary arteries.
Using metabolic imaging, UCLA researchers found that FLT-PET is a powerful predictor of treatment response and outcome in brain tumor patients. The study showed that FLT-PET imaging was predictive of patients' overall survival, with those who responded to drug treatment living three times as long as those who did not.
R. Edward Coleman received the award for his contributions to molecular imaging and nuclear medicine practice, particularly in advancing positron emission tomography (PET) for breast cancer, Alzheimer's, and brain tumors. His research has had a significant impact on medicine, and he is recognized as one of the best doctors in America.
Researchers found that FDG-PET imaging can identify patients who respond to chemotherapy, allowing for early termination of futile treatment. This improves patient care by providing an alternative approach, such as stopping chemotherapy or switching to a more adequate therapeutic option.
A new nuclear medicine technique using annexin A5 imaging may help identify individuals at risk of developing heart failure by detecting programmed cell loss in the heart muscle. This could lead to earlier intervention and improved treatment options, as cell death is a key factor in worsening left ventricular events.
Scientists have developed a method for delivering thermal ablation directly to tumor cells using nanotechnology and molecular imaging. By attaching magnetic iron-containing bioprobes to cancer cells and heating them with an alternating magnetic field, researchers were able to weaken and destroy malignant cells without damaging nearby h...
Researchers found that SPECT/CT imaging enhances sentinel node identification in overweight patients with breast cancer. The study suggests this improved technique can reduce the need for unnecessary surgery and improve treatment outcomes.
Researchers have developed a promising radiotracer, FACBC, to improve prostate cancer diagnosis and staging. The tracer shows high accumulation in cancer cells and potential for overcoming traditional PET tracers' drawbacks.
The supplement examines the role of 18F-FDG PET/CT imaging in cancer diagnosis, treatment planning, and monitoring. It provides guidelines and algorithms for the use of PET/CT in evaluating and managing head and neck cancer and thyroid cancer.
The Society of Nuclear Medicine and Molecular Imaging identifies the most promising lab-based discoveries to translate into routine patient benefit. Experts emphasize the need for shared standards, innovative approaches, and cooperation among sectors to accelerate molecular imaging's translation.
A new study published in the Journal of Nuclear Medicine found that young smokers who quit smoking can normalize abnormal coronary artery function within a month. The PET imaging study examined the effects of smoking cessation on coronary endothelial dysfunction in healthy young male adults.
Advances in PET technology enable early disease detection and personalized medicine, potentially leading to annual screenings for common diseases. Doctors will use PET's molecular imaging ability to visualize precise molecular changes, informing treatment and prevention strategies.
The Society of Nuclear Medicine and Molecular Imaging emphasizes the beneficial aspects of nuclear medicine, a highly effective diagnostic and treatment method. Every major hospital has a nuclear medicine department, performing over 19 million procedures annually, increasing by 15% from four years ago.
A recent study published in the Journal of Nuclear Medicine reveals that diabetes mellitus significantly slows nerve recovery after a heart transplant. This finding highlights the importance of understanding nervous system abnormalities to guide therapeutic efforts aimed at reducing cardiac risk for patients with diabetes.
Researchers identified an accurate method to detect coronary artery disease risk in obese individuals using stress myocardial perfusion imaging. The test can help physicians plan management strategies for patients with 'silent' disease, reducing the risk of angina, heart attack, and death.
At SNM's 53rd Annual Meeting, nearly 2,000 scientific and technologist abstracts were presented on various topics including cardiology, neurology, oncology, pediatrics, infectious disease, and more. The Society of Nuclear Medicine and Molecular Imaging also recognized individuals with named awards, lectures, and honors.
Stanford University researchers developed a 3D PET/CT imaging technique that provides a visual navigation of organs, allowing for better detection and characterization of cancer. The technology has potential for presurgical visualization, guiding biopsies and identifying tumor 'hot spots', enabling more precise diagnosis and treatment.
The publication of consensus recommendations for FDG PET usage is expected to reduce variability in clinical trials, leading to shorter trials and improved treatment outcomes. The guidelines provide a valuable reference for incorporating PET into clinical trials and promoting drug development.